Chelators as antidotes of metal toxicity: therapeutic and experimental aspects.
about
Chelation in metal intoxicationEnvironmental determinants of chronic disease and medical approaches: recognition, avoidance, supportive therapy, and detoxificationMetals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercuryPhytochelators Intended for Clinical Use in Iron Overload, Other Diseases of Iron Imbalance and Free Radical PathologyChelation: harnessing and enhancing heavy metal detoxification--a reviewCadmium toxicity and treatmentThe impact of succimer chelation on blood cadmium in children with background exposures: a randomized trialIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesManganese and acute paranoid psychosis: a case reportMagnetic nanoparticles for theragnosticsEffects of cadmium and monensin on renal and cardiac functions of mice subjected to subacute cadmium intoxicationCurrent and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder.Lead(II) binding to the chelating agent D-penicillamine in aqueous solutionAcute mercury poisoning: a case report.On the chalcogenophilicity of mercury: evidence for a strong Hg-Se bond in [Tm(Bu(t))]HgSePh and its relevance to the toxicity of mercury.Cadmium(II) N-acetylcysteine complex formation in aqueous solution.Characterizing RecA-independent induction of Shiga toxin2-encoding phages by EDTA treatmentThe role of chelation in the treatment of other metal poisonings.Effects of cadmium and monensin on spleen of mice, subjected to subacute cadmium intoxication.EDTA chelation reappraisal following new clinical trials and regular use in millions of patients: review of preliminary findings and risk/benefit assessment.Influence of FHIT on benzo[a]pyrene-induced tumors and alopecia in mice: chemoprevention by budesonide and N-acetylcysteine.Reduction in Thrombosis and Bacterial Adhesion with 7 Day Implantation of S-Nitroso-N-acetylpenicillamine (SNAP)-Doped Elast-eon E2As Catheters in SheepMonensin ameliorates cadmium-induced hepatic injury in mice, subjected to subacute cadmium intoxication.Mangiferin, a dietary xanthone protects against mercury-induced toxicity in HepG2 cells.Similarities between N-Acetylcysteine and Glutathione in Binding to Lead(II) IonsIntestinal, airway, and cardiovascular relaxant activities of thymoquinoneProtective role of N-Acetyl L-Cysteine against reproductive toxicity due to interaction of lead and cadmium in male Wistar rats.Eliminating the need for fasting with oral administration of bisphosphonates.Structural characterization of 1,3-propanedithiols that feature carboxylic acids: Homologues of mercury chelating agents.A biodistribution and toxicity study of cobalt dichloride-N-acetyl cysteine in an implantable MRI marker for prostate cancer treatment.Elimination of persistent toxicants from the human body.Cadmium toxicity revisited: focus on oxidative stress induction and interactions with zinc and magnesium.Interaction of lactic acid bacteria with metal ions: opportunities for improving food safety and quality.Potential clinical applications of chelating drugs in diseases targeting transferrin-bound iron and other metals.Regulation of the arachidonic acid mobilization in macrophages by combustion-derived particles.Quinolone resistance genes (qnrA and qnrS) in bacteriophage particles from wastewater samples and the effect of inducing agents on packaged antibiotic resistance genes.EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes.Nano drug delivery systems: a new paradigm for treating metal toxicity.Rat pancreatitis produced by 13-week administration of zinc oxide nanoparticles: biopersistence of nanoparticles and possible solutions.
P2860
Q22305611-C6354BC9-DBC5-4717-AC78-7A3ECE48EC6BQ26852713-11CDC949-FB26-44D3-BFA4-DE10AFB3D9F8Q26863224-038D0DEF-C145-453A-AA0F-4FA6AF95F30CQ26863390-1ED7CB89-508A-49BC-BAD4-C21D2558F93EQ28382983-C911FA58-9714-4AC4-AB02-50CD479F0E31Q28384540-4ADD910B-5868-4159-99BE-10B0869C7C33Q28386266-8CD8594C-2BF9-4BAD-9FE9-F21A195B52BDQ28388335-00A81F9D-F1E2-4939-B891-EBC82E779478Q28388394-1B62CB69-8215-494B-8356-5679E5FB6C29Q28389421-03FA6FC9-86C8-4467-8308-9A3540AFC5A7Q28393833-45441A1D-FA35-4FFA-8134-98D2303B0526Q30277969-CB33BA12-AA56-4D45-81EF-D2EF885B7BF6Q30540080-9524328E-05DA-4CBD-B59C-7F9B997C9EA8Q30868634-57590DD3-CDD3-4D0B-BE6E-006FA55388A0Q33543341-AD0F71AE-7F9A-4D7F-B3DE-63C2D03B7ED3Q33607422-C4FD3A21-EA8E-4B51-9766-A3A40FC8C466Q34051957-6A5A9302-6673-4270-B944-B92A19CBBC00Q34185875-354DFB9F-24B0-4392-A12C-77740E18D86BQ34376795-E9361F6A-FCBC-4FD1-87E5-0D6E8B232A48Q34628369-8101E242-B22F-4C55-8268-2D36B9E05F35Q34642777-4BB6C77D-FF53-4475-8248-F44063822B3BQ34650922-03C907C3-03BA-4C6A-9BD0-282ACAE7687DQ35077593-CE73CA11-9702-4B6D-9183-31215AD8EFB9Q35887858-7FA9560F-A152-4B79-A842-8882FA2223B8Q36354823-DAF9521E-6837-4F5C-BFD0-7FCD5B5527FCQ36395664-6FAEFEEE-5EA9-4956-BA3E-D78369BC1622Q36520886-D1AA81E2-97C4-4EA9-A0C6-779F1AF2361DQ37199126-3D191D22-1D6D-403A-95B5-C9D5BCC78628Q37245415-156506DD-1967-49E9-9B63-27AB556AA24FQ37265213-5730CF6D-AE1F-46E1-9439-8B852E0D43DDQ37476975-DECB45A2-EB2C-481A-ABD0-F9A5848B9E59Q37733171-386E742C-0B8B-4B94-80A1-AFF8A2AE727BQ37855306-352EBD9F-AA9B-4CB5-8DF3-ED4EBAB2FF3DQ38027092-ED06114D-6CC3-4DC6-AC83-9F5F6D3F8A34Q38099045-74408525-E31D-4221-829E-6C9183CFBD11Q38264314-2A5D107B-AB9C-4800-B345-1F2F345666CEQ38393200-7E91259D-2B87-4E8F-843F-50B6B47C9972Q38585738-DA5B8E9C-3E60-4404-809C-F072ABD1FFBAQ38794257-53B4525C-1CF0-4527-8D83-FB3C398A9C74Q39194754-1C6357BD-DCBC-4087-AA16-28CF3C8F091D
P2860
Chelators as antidotes of metal toxicity: therapeutic and experimental aspects.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Chelators as antidotes of metal toxicity: therapeutic and experimental aspects.
@ast
Chelators as antidotes of metal toxicity: therapeutic and experimental aspects.
@en
type
label
Chelators as antidotes of metal toxicity: therapeutic and experimental aspects.
@ast
Chelators as antidotes of metal toxicity: therapeutic and experimental aspects.
@en
prefLabel
Chelators as antidotes of metal toxicity: therapeutic and experimental aspects.
@ast
Chelators as antidotes of metal toxicity: therapeutic and experimental aspects.
@en
P2093
P1476
Chelators as antidotes of metal toxicity: therapeutic and experimental aspects.
@en
P2093
Krista Kostial
Maja Blanusa
Martina Piasek
Veda M Varnai
P304
P356
10.2174/092986705774462987
P577
2005-01-01T00:00:00Z